Freire Chadrina, M., Martin, M., Segers, K., Sépulchre, E., LEROI, N., COUPIER, J., Kalantari, H. R., Wolter, P., Collignon, J., Polus, M., Plomteux, O., Josse, C., & Bours, V. (29 May 2024). Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients. Journal of Personalized Medicine, 14 (6), 584. doi:10.3390/jpm14060584 Peer Reviewed verified by ORBi |
Gallon, R., Brekelmans, C., Martin, M., Bours, V., Schamschula, E., Amberger, A., Muleris, M., Colas, C., Dekervel, J., De Hertogh, G., COUPIER, J., Colleye, O., Sépulchre, E., Burn, J., Brems, H., Legius, E., & Wimmer, K. (24 May 2024). Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants. npj Precision Oncology, 8 (1), 119. doi:10.1038/s41698-024-00603-z Peer Reviewed verified by ORBi |
Freycon, C., Sépulchre, E., Lavallée, V.-P., Mitchell, D., MacMillan, M. L., Vezina, C., & Goudie, C. (2024). Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review. Clinical Genetics. doi:10.1111/cge.14537 Peer Reviewed verified by ORBi |
Sepulchre, E. (21 February 2024). Syndrome de prédisposition au cancer pédiatrique (SPC) [Paper presentation]. Journée des maladies rares - CHU de Liège (Institut de Cancérologie Arsène Burny), Liege, Belgium. |
Freycon, C., Sepulchre, E., & Lavallée. (November 2023). Pediatric Acute Promyelocytic Leukemia and Fanconi Anemia: Case report and literature review. Pediatric Blood and Cancer, 70 (S8), 111. Peer Reviewed verified by ORBi |
Sepulchre, E. (November 2023). Germline mutations in DDX41 in a childhood cancer cohort: Prevalence and case report. Pediatric Blood and Cancer, 70 (S8), 281. Peer Reviewed verified by ORBi |
Sepulchre, E. (March 2023). Germline variant curation and incidental findings [Paper presentation]. Provincial Tumor Board. |
KAMBALE KOMBI, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., Sepulchre, E., Bours, V., Floc'h, A., Pirenne, F., Kayembe Tshilumba, C., & Batina-Agasa, S. (2022). Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo. Transfusion Medicine. doi:10.1111/tme.12939 Peer Reviewed verified by ORBi Dataset: 10.1111/tme.12939 |
Sepulchre, E., Minon, J.-M., Paridaens, H., Stojkovic, V., Ketelslegers, O., & Dresse, M.-F. (2022). P-044: RETROSPECTIVE STUDY OF POST-TRANSFUSION ALLOIMMUNIZATION IN THE SICKLE CELL POPULATION OF THE CHR CITADELLE. In HemaSphere. EHA. doi:10.1097/01.hs9.0000873072.90171.fd Peer reviewed |
Kambale-Kombi, P., Marini Djang'Eing'A, R., ALWORONG’A OPARA, J., MINON, J., Sepulchre, E., Bours, V., FLOCH, A., PIRENNE, F., KAYEMBE TSHILUMBA, C., & BATINA AGASA, S. (August 2022). P-035: RED BLOOD CELL ALLOIMMUNIZATION IN SICKLE CELL DISEASE PATIENTS IN THE DEMOCRATIC REPUBLIC OF THE CONGO. HemaSphere, 6, 34-34. doi:10.1097/01.hs9.0000873036.01916.17 Peer Reviewed verified by ORBi Dataset: 10.1097/01.HS9.0000873036.01916.17 |
Sepulchre, E. (July 2022). Pediatric cancer: When to consider a hereditary predisposition syndrome? [Paper presentation]. Kinshasa Reference Center for Rare and Undiagnosed Diseases seminar, Kinshasa, Congo - Kinshasa. |
Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581 Peer Reviewed verified by ORBi |
Sepulchre, E., Pittie, G., Stojkovic, V., Haesbroeck, G., Crama, Y., Schyns, M., Paridaens, H., de Marchin, J., Degesves, S., Biemar, C., Boccar, S., Senterre, J.-M., & Minon, J.-M. (2022). Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution. Acta Clinica Belgica, 77 (2), 261-267. doi:10.1080/17843286.2020.1822078 Peer Reviewed verified by ORBi |
SEPULCHRE, E., Daubie, V., Adam, A.-S., Cotton, F., & Gulbis, B. (September 2021). Hereditary spherocytosis: How to optimize its diagnosis. Belgian Journal of Paediatrics, 23 (3), 230-5. Peer Reviewed verified by ORBi |
SEPULCHRE, E., Stojkovic, V., Paridaens, H., Senterre, J.-M., & Minon, J.-M. (November 2020). Evaluation of ROCHE Anti-SARS-CoV-2 ECLIA and comparison with 4 other assays. Poster at RBSLM annual meeting [Poster presentation]. Annual meeting of Royal Belgian Society of Laboratory Medicine, Bruxelles, Belgium. Editorial reviewed |
SEPULCHRE, E., Adam, A.-S., Cotton, F., Lazarova, E., & Gulbis, B. (June 2019). Hereditary spherocytosis : screening and diagnostic approach in a Belgian laboratory. HemaSphere, 3 (1), 548. doi:10.1097/01.HS9.0000563096.36433.6b Peer Reviewed verified by ORBi Dataset: 10.1097/01.HS9.0000563096.36433.6b |
Sepulchre, E. (March 2019). Hereditary spherocytosis: How to optimize our diagnostic approach? [Paper presentation]. Red Blood Cell Disorder meeting. |
SEPULCHRE, E. (March 2019). La sphérocytose héréditaire en Belgique: Huit années d’expérience diagnostique [Poster presentation]. Congrès annuel de la SFH. Editorial reviewed |
Sepulchre, E. (June 2017). A propos d’une cassure de la courbe pondérale [Paper presentation]. Luxembourg annual pediatric meeting. |
Sepulchre, E., Ketelslegers, O., Minon, J.-M., & DRESSE, M.-F. (March 2016). Newborn screening for sickle cell disease : 13 years at the CHR "La Citadelle", Liège. Tijdschrift van de Belgische Kinderarts, 18 (1), 107. Peer reviewed |
RADERMECKER, R., PHILIPS, J.-C., & Sepulchre, E. (March 2015). Analyse rétrospective des données concernant les patientes avec diabète gestationnel au CHU de Liège. Diabetes and Metabolism, 41, 46. Peer Reviewed verified by ORBi |
SEPULCHRE, E. (March 2015). Atypical bifocal intracranial tumor: A case report [Poster presentation]. Congrès annuel de la SBP. Peer reviewed |
RADERMECKER, R., Sepulchre, E., & CONTESSI, E. (March 2014). Enquête concernant les connaissances de l’acido-cétose de patients diabétiques de type 1suivis régulièrement dans la convention hospitalière du CHU. Diabetes and Metabolism, 40, 11. Peer Reviewed verified by ORBi |
SEPULCHRE, E. (March 2014). Interprétation et interférences dans le dosage de l’hémoglobine glyquée : un cas d’HbA1c indosable [Poster presentation]. Congrès annuel de la SFD, Paris, France. Editorial reviewed |
Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503. Peer reviewed |
Sepulchre, E., & RADERMECKER, R. (December 2013). Les inhibiteurs du cotransporteur du glucose SGLT rénal: une nouvelle classe thérapeutique dans le diabète de type 2. Journal de Cardiologie, 25 (8), 429-434. |
RADERMECKER, R., & Sepulchre, E. (October 2013). De la molécule au médicament: comment ça se passe? Revue de l'Association Belge du Diabète, 56. Peer reviewed |
RADERMECKER, R., & Sepulchre, E. (March 2013). Mesure continue du glucose et diabète gestationnel : revue des études disponibles. Diabetes and Metabolism, 39, 119-A120. Peer Reviewed verified by ORBi |
RADERMECKER, R., & Sepulchre, E. (January 2013). Les pompes à insulines et les insulines d'aujourd'hui. Urgence Pratique, 116, 23-26. Peer reviewed |